Skip to content
Search

Latest Stories

Pharmacist receives Dr. Falk/Guts UK Awards 2024 for transforming Autoimmune Hepatitis care

Pharmacist receives Dr. Falk/Guts UK Awards 2024 for transforming Autoimmune Hepatitis care
Pharmacist, Sonal Patel, has won Dr. Falk/Guts UK Awards 2024 for revolutionizing the management of autoimmune hepatitis with her innovative patient care approach

In a notable accolade for outstanding contributions to healthcare, a Specialist Hepatology pharmacist, Sonal Patel, has been awarded the Dr. Falk/Guts UK Award 2024 for the Pharmacist Recognition prize winner category.

Patel, who works at the Guy's and St Thomas' Hospital, received the award for her ground-breaking work in improving the management of autoimmune hepatitis (AIH) and was presented with her award by BSG Chair Prof Andy Veitch & Dr Riadh Jazrawi, Medical Director, Dr Falk Pharma UK, at an event  during the British Society Gastroenterology annual meeting in Birmingham recently.


Autoimmune Hepatitis (AIH) is a chronic liver disease characterized by the immune system mistakenly attacking the liver cells, leading to inflammation and potential liver damage.

Patel worked on the establishment of a dedicated specialised pathway to optimise the management of patients diagnosed and treated for autoimmune hepatitis (AIH).

The project highlighted her innovative approach to patient care, which has significantly enhanced treatment outcomes for individuals suffering from AIH.

According to her, prior to the intervention, the management of AIH relied heavily on hepatology consultant clinics, leading to long waiting times and inconsistent patient support.

To address these challenges, Patel collaborated with her team to "redesign our treatment and monitoring pathway for patients with autoimmune hepatitis".

This initiative led to the creation of pharmacist-led immunosuppressant monitoring clinics, integrated into existing pharmacy services at the hospital.

"The management of autoimmune hepatitis(AIH) encompasses the use of steroids and long-term immunosuppression to control hepatic inflammation," Patel explained.

"Close monitoring and careful titration of these medicines are required to strike a balance between achieving therapeutic benefit whilst minimising the risk of adverse effects."

Patel’s approach also included the development of patient information leaflets, an email helpline for direct communication, and both virtual and face-to-face consultations.

This multifaceted strategy has enabled a more responsive and flexible patient care model, including home medication delivery and shared care protocols.

pharmacist; Image Credit: Dr Falk/Guts Awards 2024

"I felt it was important to make pharmacist-led services central to this pathway. By focusing on optimising medication safety, efficacy and adherence, this was an opportunity to showcase our skillset and strengths, and a pertinent example of how pharmacists can directly support the wider multidisciplinary team (MDT) with patient care," said Patel.

"It has been rewarding to see the impact of the pharmacy service on our patients. Several patients previously lost to follow up have since re-engaged with our services, and we have received positive feedback through patient experience forums."

Dr. Sreelakshmi Kotha, Consultant Hepatologist at Guy’s and St Thomas’, praised Patel’s efforts, stating, "Sonal has been actively involved in setting up and running the

pharmacist autoimmune hepatitis clinic at the GSTT alongside hepatology consultants.

"These weekly clinics significantly improved the quality of care provided to autoimmune hepatitis patients and reduced the pressures on consultant clinics.

In particular the clinics have supported us to manage the cohort of patients who struggle with compliance to medications.

"It would be much more difficult to run the autoimmune hepatitis service without the availability of the pharmacy clinic."

Expressing her gratitude, Patel said, “This award is a wonderful recognition of the impact pharmacists can have on patient outcomes.

"It underscores the essential role we play as part of the multi-disciplinary team and highlights the value of pharmacist-led services."

Dr. Falk/Guts UK Awards are renowned for honouring exceptional contributions to the fields of gastroenterology and hepatology.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less